Author: Marialuisa Zedde, MD, Arcispedale Santa Maria Nuova IRCCS, Reggio Emilia, Italy ESO organized this workshop in Munich on November 16 2017 just before the Garmish conference. The aim of this workshop was to detail methodological issues in guidelines production, mainly following step by step the GRADE methodology. Both speakers and talks in […]
Authors: Diana de Sousa and Antje Schmidt Since its inception in 2011, the European Stroke Science Workshop has become a cornerstone of ESO’s academic activities and a true “must go” for researchers in the field. This year, ESO convened again > 120 stroke experts to the Eibsee near Garmisch-Partenkirchen in Germany to discuss hot topics […]
Author and affiliations: Dr. Melinda B. Roaldsen UiT, The Arctic University of Norway, Department of Clinical Medicine and The Neurological Department at the University Hospital of North Norway, Tromsø, Norway Approximately 1 in 5 acute ischaemic strokes occur during sleep.1-3 We know that clotbusting treatment with alteplase given within 4,5 hours of symptom […]
Having in mind that he was one of the editors of the important 2006 Helsingborg Declaration on European stroke strategies, the European Stroke Organisation and SAFE are proud and honored to have Prof. Norrving now coordinating a joint ESO and SAFE project called “Stroke Action Plan for Europe 2018-2030”. SAFE: Stroke Support Organisations are only just […]
During the period between 18-20 October 2017 the 5th MENA stroke conference was held in Cairo. The biggest stroke event in the middle east this year. At the conference, there was a press release to increase stroke awareness in the society that was attended by Prof. Valeria Caso. There were more than 600 delegates from […]
Author: Dr Nicolas Martinez-Majander, University of Helsinki and Department of Neurology, Helsinki University Hospital, Finland What is the concept of ESUS? Up to 25% of all ischemic strokes are considered cryptogenic according to TOAST classification and this proportion can increase up to 40% in younger cohorts.1,2 However, cases with multiple causes and cases with an […]
Based on the paper “Recommendations to Establish a Stroke Unit and Stroke Centre” the ESO built this important project. It was the task of the Stroke Unit Committee to define the submission documents, the evaluation criteria and the overall process. The aim of the Stroke Unit Committee is to standardise and equalise care for patients […]
Author: Antje Schmidt (Klinik für Neurologie, Universitätsklinikum Münster, Germany) What’s the most effective secondary prevention in cardiovascular disease? That’s what vascular neurologists, cardiologists, angiologists and general practitioners alike have been pondering about for years. Established prevention strategies include antihypertensives, statins, diabetes control, life style modification and antiplatelets. Until now, the standard antiplatelet drug for most […]
ESO successfully organized on 10 October 2017 a high-level workshop with EU policy-makers on access to stroke treatment and innovation, the first of its kind, which took place in the European Parliament, in Brussels. The event brought together more than 50 representatives from ESO and the EU institutions, physicians and patients with the aim of […]